BioCentury
ARTICLE | Regulation

How omics will drive the next generation of surrogate endpoints

Next-gen tools offer more complete views of disease, drug response, but constraining their outputs is key

August 31, 2021 1:08 PM UTC

As omics tools find their footing in the clinic, they have the potential to reveal new, more predictive surrogate endpoints, and bolster confidence in existing ones. These emerging ...



Access this Article